Company: INMB
Filing Date: 2025-03-07
Form Type: 424B5
Source: 0001213900-25-021719
Chunk: 2

Company: Inmune Bio, Inc.
Filing Date: 2025-03-07
Form: 424B5
Chunk 2
---
 the accompanying prospectus, together with the information incorporated by
reference as described under the heading “Incorporation of Certain Information by Reference” in this prospectus supplement.
These documents contain important information that you should consider when making your investment decision.

This document is in two parts.
The first part is this prospectus supplement, which describes the specific terms of this offering and also adds to and updates information
contained in the accompanying prospectus and the documents incorporated by reference herein or therein. The second part, the accompanying
prospectus, provides more general information. Generally, when we refer to this prospectus, we are referring to both parts of this document
combined. To the extent there is a conflict between the information contained in this prospectus supplement, on the one hand, and the
information contained in any document incorporated by reference into this prospectus supplement that was filed with the Securities and
Exchange Commission (the “SEC”), before the date of this prospectus supplement, on the other hand, you should rely on the
information in this prospectus supplement. If any statement in one of these documents is inconsistent with a statement in another document
having a later date—for example, a document incorporated by reference into this prospectus supplement—the statement in the
document having the later date modifies or supersedes the earlier statement.

We further note that the representations,
warranties and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference herein
or in the accompanying prospectus were made solely for the benefit of the parties to such agreement, including, in some cases, for the
purpose of allocating risk among the parties to such agreement, and should not be deemed to be a representation, warranty or covenant
to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such representations,
warranties and covenants should not be relied on as accurately representing the current state of our affairs.

You should rely only on the
information contained or incorporated by reference in this prospectus supplement and the accompanying prospectus. We have not authorized
any other person to provide you with different information. If anyone provides you with different or inconsistent information, you should
not rely on it. We are not making an offer to sell or seeking an offer to buy our common stock under this prospectus in any jurisdiction
where the offer or sale is not permitted. Persons outside the United States who come into possession of this prospectus